Skip to main content
. Author manuscript; available in PMC: 2010 May 26.
Published in final edited form as: Mol Cell Pharmacol. 2010;2(2):61–68.

Figure 9. Mutation of lysine 40 or aspartic acid 136 or double mutations abolishe HIPK4 kinase activity.

Figure 9

Human 293 kidney cells were transiently transfected with expression vectors carrying wild type or mutant S-tagged HIPK4. Cells were also transfected with same vector without HIPK4 insert. Cell lysates were prepared for S-tag protein pull-down and the pull-down precipitates were subjected to in vitro kinase assay using [γ-32P]-ATP and MBP as a substrate. Signals indicating phosphorylated proteins were detected by autoradiography.